Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Next Generation Molecular Assay Market Overview

The global next generation molecular assay market was valued at around US$ 4,976.30 Million at the end of 2021. The market is projected to register a 5.16% CAGR and top a valuation of US$ 8,654.92 Million by 2032.

The market for next generation molecular assay market is anticipated to propel due to factors such technological development, an ageing population, and rising demand for genetic testing.

Worldwide, there has been a growth in the use of next-generation molecular assays due to a number of advantages over traditional testing, including the ability to do multiple assays, reliable results, and faster processing. High degree of precision has been achieved by next generation molecular test.

The use of next-generation molecular assays in therapeutic medication monitoring and drug prescription selection with the aim of avoiding toxicity and other adverse effects has been made possible by benefits including fewer mistakes and improved detection and quantification.

Attributes

Details

Next Generation Molecular Assay Market Value in 2021

US$ 4,976.30 Million

Next Generation Molecular Assay Market Value in 2032

US$ 8,654.92 Million

Next Generation Molecular Assay Market CAGR (2022 to 2032)

5.16%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Major Drivers Boosting the Demand for Next Generation Molecular Assay Market?

A significant factor driving the global market for next-generation molecular assays is improved reimbursement regulations. An increasing trend in the global market for next generation molecular assays, including genomics and proteomics, is likely to fuel the industry's expansion. These assays were created as a result of improvements in in-vitro detection techniques.

The ability to identify novel virus variants, genomic alterations in pathogens, and other advancements related to next generation molecular assays are some of the reasons supporting the growth of the next generation molecular assay market.

Which Region Shows Strong Growth Potential in the Next Generation Molecular Assay Market?

The Next Generation Molecular Assay Market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America is anticipated to have a dominating position in the global next generation molecular assay market as a result of rising R&D spending, advantageous reimbursement scenarios, and a growing emphasis on creating cutting-edge technologies.

Moreover, Asia Pacific is expected to have a significant growth potential for the next generation molecular assay market during the forecast period due to the rising number of R&D facilities and rising government spending on healthcare.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who are the Key Manufacturers in the Next Generation Molecular Assay Market?

Thermo Fisher Scientific Inc, Invivoscribe, Myriad Genetics Inc, Becton, Dickinson and Company, Molecular Devices, LLC, Luminex Corporation, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Tecan Trading AG, Agilent Technologies Inc, and Danaher Corporation.

Scope of Report

Report Attributes

Details

Growth Rate

CAGR of 5.16% 2022 to 2032

Base Year for Estimation

2021

Historical Data

2012 to 2021

Forecast Period

2022 to 2032

Qualitative Units

Revenue in USD Million, Volume in Units, and CAGR from 2022 to 2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segment Covered

  • Test Type
  • Technique
  • End-User
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • USA
  • Canada
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • BENELUX
  • China
  • Japan
  • South Korea
  • India
  • Malaysia
  • Thailand
  • Indonesia
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • North Africa
  • Turkey

Key Players

  • Thermo Fisher Scientific Inc
  • Invivoscribe
  • Myriad Genetics Inc
  • Becton, Dickinson and Company
  • Molecular Devices, LLC
  • Luminex Corporation
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • Tecan Trading AG
  • Agilent Technologies Inc
  • Danaher Corporation

Customization

Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered in the Next Generation Molecular Assay Market Survey

By Test Type:

  • Virus testing
  • HPV testing
  • HIV testing
  • Influenza testing
  • HCV testing
  • Others
  • Blood Testing
  • Genetic Testing
  • Oncological Testing
  • STD Testing

By Technique:

  • Polymerase chain reaction (PCR)
  • Enzyme-Linked Immuno-Sorbent Assay (ELISA)
  • Microarrays
  • Gene expression profiling assays
  • Others

By End-user:

  • Hospitals
  • Academic & Research Centers
  • Biopharmaceutical Companies
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Growth Outlook for the Global Next Generation Molecular Assay Market?

The global next generation molecular assay market is anticipated to register a CAGR of 5.16% during the forecast period.

Who are the Prominent Players in the Next Generation Molecular Assay Market?

Thermo Fisher Scientific Inc, Invivoscribe, Myriad Genetics Inc, Becton, Dickinson and Company, Molecular Devices, LLC, Luminex Corporation, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Tecan Trading AG, Agilent Technologies Inc, and Danaher Corporation., among others are some prominent next generation molecular assay market players.

Explore Healthcare Insights

View Reports

Next Generation Molecular Assay Market

Schedule a Call